Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers

Author： Knight William D.  

Publisher： Oxford University Press

ISSN： 1460-2156

Source： Brain, Vol.134, Iss.1, 2011-01, pp. : 293-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimers disease

By Kadir Ahmadul  

Brain, Vol. 134, Iss. 1, 2011-01 ,pp. : 301-317

Oxford University Press

Access to resources Recommend Favorite

Amyloid β Accumulation Assessed with <sup>11</sup>C-Pittsburgh Compound B PET and Postmortem Neuropathology

By  

Current Alzheimer Research, Vol. 12, Iss. 3, 2015-03 ,pp. : 278-286

Bentham Science Publishers

Access to resources Recommend Favorite

Detection of brain amyloid β deposition in patients with neuropsychological impairment after traumatic brain injury: PET evaluation using Pittsburgh Compound-B

By Kawai Nobuyuki  

Brain Injury, Vol. 27, Iss. 9, 2013-08 ,pp. : 1026-1031

Informa Healthcare

Access to resources Recommend Favorite

In vivo visualization of -synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy

By Kikuchi Akio  

Brain, Vol. 133, Iss. 6, 2010-06 ,pp. : 1772-1778

Oxford University Press

Access to resources Recommend Favorite

Amyloid and Tau Positron Emission Tomography in Suggested Diabetesrelated Dementia

By  

Current Alzheimer Research, Vol. 15, Iss. 11, 2018-09 ,pp. : 1062-1069

Bentham Science Publishers

Access to resources Recommend Favorite